Levetiracetam Sandoz (Levetiracetam)

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This binding reduces calcium‑dependent exocytosis of excitatory neurotransmitters, thereby decreasing neuronal hyper‑excitability and lowering the likelihood of seizure propagation.

The dosage of Levetiracetam Sandoz is individualized by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. The prescriber determines the appropriate starting dose and titration schedule to achieve optimal seizure control while minimizing side effects.

Safety data for levetiracetam in pregnancy are limited, and the product is classified as pregnancy category unknown. It should only be used if the potential benefit outweighs the potential risk to the fetus. Breastfeeding is not contraindicated, but the infant may be exposed through milk; a risk‑benefit assessment is recommended.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Levetiracetam offers a favorable pharmacokinetic profile with minimal protein binding and few drug‑enzyme interactions, distinguishing it from older agents such as carbamazepine or phenytoin, which are strong enzyme inducers. Compared with valproate, levetiracetam has a lower risk of hepatotoxicity and weight gain, though behavioral changes may be more common.

Store the tablets at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not store in bathrooms or other humid environments.

Levetiracetam Sandoz is taken orally, usually with a glass of water. Tablets can be swallowed whole; they may be taken with or without food. The exact timing and frequency are determined by the prescribing clinician to maintain consistent plasma levels.

Serious adverse events include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, and psychiatric disturbances like aggression, depression, or suicidal thoughts. Patients should seek immediate medical attention if they develop rash, blistering, mood changes, or thoughts of self‑harm.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is advised for patients with severe renal impairment, as dose adjustment may be required, and for those with a history of serious psychiatric disorders.